You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

MEPERIDINE AND ATROPINE SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Meperidine And Atropine Sulfate patents expire, and what generic alternatives are available?

Meperidine And Atropine Sulfate is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MEPERIDINE AND ATROPINE SULFATE?
  • What are the global sales for MEPERIDINE AND ATROPINE SULFATE?
  • What is Average Wholesale Price for MEPERIDINE AND ATROPINE SULFATE?
Summary for MEPERIDINE AND ATROPINE SULFATE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:MEPERIDINE AND ATROPINE SULFATE at DailyMed
Drug patent expirations by year for MEPERIDINE AND ATROPINE SULFATE

US Patents and Regulatory Information for MEPERIDINE AND ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst MEPERIDINE AND ATROPINE SULFATE atropine sulfate; meperidine hydrochloride INJECTABLE;INJECTION 085121-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.